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Abstract
Background: The use of cytology brushes for the purpose of obtaining respiratory cells from
adults for clinical and research purposes is well established. However, the safety and utility of non-
bronchoscopic brushings to study the paediatric airway has not been assessed. The purpose of this
study was to assess the practicality of using non-bronchoscopic brushing to sample epithelial cells
from children for investigation of epithelial function in health and disease using a wide range of
molecular and cellular techniques.
Methods: Non-bronchoscopic brushing was investigated in a non-selected cohort of healthy, and
mildly asthmatic children presenting for surgery unrelated to respiratory conditions, at the major
children's hospital in Perth. Safety and side-effects of the procedure were assessed. Cell number,
phenotype and viability were measured for all samples. The potential of these cells for use in long-
term cell culture, immunohistochemistry, western blotting, quantitative PCR and gene arraying was
examined.
Results: Non-bronchoscopic brushing was well tolerated in all children. The only significant side
effect following the procedure was cough: nursing staff reported cough in 20% of patients; parents
reported cough in 40% of patients. Cells sampled were of sufficient quantity and quality to allow
cell culture in 93% of samples. Similarly, protein and RNA extracted from the cells was suitable for
investigation of both gene and protein expression using micro-array and real-time PCR.
Conclusion: Non-bronchoscopic brushing in children is safe and easy to perform, and is not
associated with any complications. Using this technique, adequate numbers of epithelial cells can be
retrieved to allow cell culture, western blotting, real time PCR, and microarray analysis. The
purpose of this study is to demonstrate the utility of non-bronchoscopic airway brushing to obtain
and study epithelial cells and to encourage others so that we can accelerate our knowledge
regarding the role of the epithelium in childhood respiratory disease.
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Background
The use of cytology brushes for the purpose of obtaining
respiratory cells from adults for clinical and research pur-
poses is well established. This technique is generally
reported to be safe, both in adults with pulmonary disease
and in healthy volunteers [1]. Samples are usually
obtained under direct vision using a bronchoscope. How-
ever, we and others have recently used non-broncho-
scopic brushing to sample airway epithelial cells from
children [2,3]. This method has several advantages over
bronchoscopic brushing as it is simple and quick to per-
form, and there is no need for a bronchoscope. Although
we have now successfully used this method in combina-
tion with a variety of cellular and molecular techniques to
investigate the role of the epithelium in childhood
asthma, initially, very little had been published on the
topic. In addition, the difficulty in obtaining target organ
tissue from children has meant that most information
regarding common childhood diseases such as asthma
has been derived from studies performed in adults.
We currently understand little about the molecular mech-
anisms involved in the pathogenesis of asthma. The air-
way epithelium is an especially attractive target in which
to identify new molecular mechanisms and therapeutic
targets because it is critically involved in the development
of asthma as the first cell of contact with the environment.
This is particularly pertinent since it is likely that dysregu-
lated epithelial repair in childhood asthma is a critical
determinant of disease progression in adults. To this end,
the available evidence suggests that epithelial fragility and
dysfunction as well as accumulation of sub-epithelial
fibroblasts and remodelling of the airway wall in asthma
can occur early in childhood [4].
The purpose of this report is to summarise our experiences
with non-bronchoscopic epithelial brushing techniques
and subsequent sample processing. We have detailed the
use of cells for gene and protein expression, and for cell
culture. The use of primary culture systems has important
advantages over the use of immortalized cell lines, and
allows functional experiments to be conducted. We aim to
encourage the use of these techniques to study normal
developmental processes in the lung and the early patho-
physiology of respiratory diseases.
Methods
Children admitted to Princess Margaret Hospital for the
purposes of elective surgery for non-respiratory com-
plaints were recruited for this study. Children were usually
having minor gastrointestinal or ear, nose and throat sur-
gery. The study was approved by the Princess Margaret
Hospital for Children Ethics Committee, and written
informed consent was obtained from the parents of the
children prior to sampling (see appendix for parent infor-
mation sheet). The asthmatic and atopic backgrounds of
the children were determined by allergen-specific IgE test-
ing and a validated asthma and allergy questionnaire was
administered to the parent or legal guardian [5]. Prior to
surgery, each child was anaesthetised and intubated. A
nylon cytology brush (BC 25105, Olympus, Australia)
was used to sample cells from the airway. The plastic
sheath protecting the brush was removed and discarded,
as retracting the brush into the tightly fitting sheath would
dislodge cells. The unprotected brush was inserted directly
through the endotracheal tube, advanced until resistance
was felt, and rubbed against the epithelial surface to sam-
ple cells. The brush was then withdrawn and the tip cut off
into 5 ml of culture media (RPMI-1640 containing 10%
(v/v) heat inactivated foetal calf serum). This process was
repeated at least once.
A sub-group of twenty five of these children was studied
to assess how well the technique was tolerated. Respira-
tory variables were monitored before, during, and after
the brushing procedure. Symptoms following the brush-
ing were recorded by contacting the parents within one
week of the procedure. Children who underwent non-
bronchoscopic brushing (12 male, mean age 10.2, SE
0.71) were compared to 24 control children who were
anaesthetised and intubated only for similar procedures
(15 male, mean age 10.9, SE 0.76).
Sample Processing
Epithelial cells were collected into RPMI-1640 containing
10% (v/v) heat inactivated foetal calf serum. Samples
were processed immediately. An aliquot of the cell sus-
pension was diluted 1:2 with 0.4% trypan blue, and
applied to a haemocytometer. The total number of cells,
and the percentage of viable cells, was determined under
a light microscope, within 15 minutes of collection. Each
sample of cells obtained by non-bronchoscopic brushing
was processed to allow for use in multiple investigative
techniques; 1 × 106 cells were used for cell culture or pro-
tein extraction, 0.5 × 106 cells to produce cytospin slides
for immunocytochemical studies, and RNA was extracted
from the remaining 1 × 106 cells.
For culture, cells were washed once in RPMI-1640 media
and the cell pellet resuspended in bronchial epithelial
basal media (BEBM, Clonetics, CA) supplemented with
bovine pituitary extract (50 mM), insulin (5 mM), hydro-
cortisone (0.5 mM), gentamicin (0.001%, v/v), ampho-
tericin B (0.0005%, v/v), retinoic acid (0.1 µM),
transferrin (10 mM), triiodothyronine (6.5 µM), epine-
phrine (6.5 µM) and human recombinant epidermal
growth factor (EGF: 0.5 µM). The cells were then seeded
into a culture vessel (25 cm2 growth surface area) pre-
coated with a mixture of fibronectin, collagen and bovine
serum albumin, and maintained at 37°C in a humidifiedRespiratory Research 2005, 6:53 http://respiratory-research.com/content/6/1/53
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incubator. Twenty-four hours post-isolation, unattached
cells were collected. These cells were reseeded into the
same culture vessel, with fresh media containing Ultroser
G (2% v/v; BioSepra, CA), a serum substitute. The collec-
tion and reseeding of viable unattached cells was repeated
at both 48 and 72 hours post isolation. Subsequent cul-
tures were fed every second day and were usually passaged
every 13–16 days.
Before the remaining cell suspension was used for protein
and RNA extraction, and to produce cytospin slides, the
macrophages were removed by positive selection: the cell
suspension was added to a culture dish that had been pre-
viously coated with CD-68 antibody (Dako, Australia).
The plate was incubated for 20 minutes (37°C, 5% CO2)
to allow the macrophages to adhere. The suspended epi-
thelial cells were aspirated from the plate, and the macro-
phages removed using trypsin (0.25%) for subsequent
analysis. The macrophage depleted cell suspension was
used to produce cytospins, extract protein, and extract
RNA.
Cytospin slides were prepared by centrifuging epithelial
cells onto a glass slide in a cytocentrifuge (Hettich). Slides
were air dried, fixed in 4% paraformaldehyde for 10 min-
utes, and then stored at -20°C until required. Immunocy-
tochemical staining of the cytospins was used to confirm
the purity of the epithelial sample. Antibodies against
cytokeratin (a marker for tissue of epithelial origin), α  -
smooth muscle actin (a marker of myofibroblasts, myoep-
ithelial cells and smooth muscle cells), smooth muscle
myosin (a marker of smooth muscle cells), and vimentin
(a marker of mesenchymal cells) were used to confirm
epithelial cell phenotype.
Immunocytochemical techniques provide only semi-
quantitative data about protein expression, and are not
sensitive enough to determine levels of protein expression
accurately; therefore protein was extracted for analysis
with Western blotting. Protein was extracted from the pel-
leted epithelial cells by lysing the cells in 200 µl of an SDS
extraction buffer (20 mM Tris, 1 mM SDS, 1 mM DTT) in
the presence of protease inhibitors (Sigma). A commercial
assay (Micro BCA Protein Assay, Pierce Biotechnology)
was used according to the manufacturers instructions to
determine the concentration of total protein in the cell
lysate. For each sample, 50 µg of protein was subjected to
12% SDS-PAGE, and immunoblotted with anti-β -actin
antibody. Antibody binding was detected with ECL Plus
Western Blotting Detection Reagents (Amersham
Biosciences).
Total RNA was extracted from epithelial cells using the
QIAGEN RNeasy kit (Vic, Australia). RNA quality and
quantity was assessed using the Agilent Bioanalyser (Vic,
Australia). RNA was prepared from 18 subjects according
to a modified version of the protocol of Baugh et al [6]
and hybridised to microarrays. For our first study, gene
expression profiles from 9 mild, asymptomatic asthmatics
were compared to 9 healthy children for a total of 18
arrays. Expression of genes in cells from asthmatic and
healthy children was compared using Affymetrix Human
Genome U133 Arrays (HG-U95Av2), which examine the
expression of approximately 23,000 genes. Real-time PCR
was used to validate the array data for specific genes. Real-
time PCR was conducted as previously described [3].
Data was reported as mean (SE) and analysed by inde-
pendent samples t-test. Significance was taken as p < 0.05.
The proportion of basal cells was analysed using analysis
of variance (ANOVA) to compare the difference between
the three phenotype groups.
Results
The procedure is well tolerated
The only significant adverse event reported after the pro-
cedure was cough (Table 1). The nursing staff recorded
cough in 20% of patients undergoing brushing. Parentally
reported cough was higher, with 40% of parents reporting
cough in those children undergoing the procedure. Cough
persisting longer than 4 hours was recorded in 32% of
patients, and 28% had cough persisting to the following
day. Despite this, 100% of parents said that if asked by a
friend "Should my child participate in this study?" they
would answer "yes". Children who underwent non-bron-
choscopic brushing were, on average, ventilated for a
longer period than the control group (27 vs. 22.3 min),
but this was not statistically significant (p = 0.066, table
1). There was no difference in any other clinical variables
recorded, including the lowest level of oxygen saturation,
and the time spent in recovery.
Symptoms and respiratory variables were compared
between asthmatic and non-asthmatic children undergo-
ing non-bronchoscopic brushing (Table 2). The nursing
staff did not record cough in any of the asthmatic patients.
Parentally reported cough was higher in the asthmatic
subjects (43% vs. 39%), but this was not statistically sig-
nificant (p = 0.863). Parents of asthmatic children also
reported a higher level of cough persisting to the follow-
ing day (43% vs. 22%), however this was not statistically
significant (p = 0.322).
Epithelial cell retrieval and processing
The mean cell retrieval from 151 brushings was 2.67 × 106
cells (SE = 0.16 × 106, Figure 1A) and on average, 17.3%
of cells were viable (SE = 2.15%, Figure 1B). The number
or viability of cells retrieved was not related to asthmatic
or atopic status. The epithelial phenotype of the cells was
confirmed by immunostaining (Figure 2). To confirm thatRespiratory Research 2005, 6:53 http://respiratory-research.com/content/6/1/53
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the population of epithelial cells sampled did not vary
between phenotypes, the number of cells expressing the
basal cell marker isolectin B4 was determined. The pro-
portion of basal cells was independent of phenotype (Fig-
ure 3).
In our hands, the cell culture success rate is such that 93%
of samples exhibit some growth, 80% grow to confluence,
and 80% survive a second passage. Initial cultures con-
sisted of a heterogeneous cell population composed of
both terminally differentiated epithelial cells as indicated
by the presence of cilia, but also non-ciliated epithelial
cells. Subsequently passaged cultures were found to solely
exhibit the non-ciliated epithelial morphology. No differ-
ences in cellular morphology have been observed between
cultures established from healthy and asthmatic pheno-
types. Established cultures have been successfully grown
up to passage 7. When the cells reach 80% confluence in
their second passage (Figure 4), they are used for func-
tional studies.
Protein was extracted from the epithelial cells; the average
protein yield was 74 µg (SE = 8.79 µg, N = 18) per 1 × 106
cells. This was sufficient for detection of β -actin using
Western blotting, demonstrating the feasibility of deter-
mining protein expression from cells obtained by the
non-bronchoscopic brushing technique.
RNA extraction yielded on average 2.9 µg of RNA (SE =
0.21, N = 58, Figure 5A), as assayed by Agilent Bioanalyser
(Vic, Australia). The ribosomal RNA ratio was used as a
measure of RNA quality; the average ratio was 1.52 (SE =
Table 1: Symptoms following non-bronchoscopic brushing. Symptoms following non-bronchoscopic brushing, and observations of 
respiratory parameters before, during, and after brushing. Cough was the only reported symptom, and all parents said they would 
recommend the study to a friend.
Controls mean (SE) Sampled mean (SE) p-value
Number of participants 24 25 -
Cough recorded 0% 20% (8%) 0.022
Parental reported cough - 40% (10%) -
Cough > 4 h - 32% (9%) -
Cough following day - 28% (46%) -
Recommend to friend? - 100% (0%) -
Length of Ventilation (mins) 22.3 (1.85) 27 (1.68) 0.066
Lowest oxygen saturation 98.6 (0.12) 96.8 (1.02) 0.083
Supplemental oxygen 79% (8%) 80% (8%) 0.944
Highest respiratory rate 22.7 (0.77) 22.2 (0.58) 0.607
Time in recovery (mins) 21.5 (2.22) 18.4 (1.40) 0.246
Table 2: Symptoms following non-bronchoscopic brushing. Comparison of symptoms following non-bronchoscopic brushing, and 
observations of respiratory parameters before, during, and after brushing in asthmatic and non-asthmatic patients.
Non-asthma mean (SE) Asthma mean (SE) p-value
Number of participants 18 7 -
Cough recorded 28% (11%) 0% (0%) 0.129
Parental reported cough 39% (12%) 43% (20%) 0.863
Cough > 4 h 28% (11%) 43% (20%) 0.489
Cough following day 22% (10%) 43% (20%) 0.322
Recommend to friend? 100% (0%) 100% (0%) -
Length of Ventilation (mins) 28.9 (1.92) 22.1 (2.86) 0.071
Lowest oxygen saturation 96.9 (1.33) 96.4 (1.46) 0.845
Supplemental oxygen 83% (9%) 71% (18%) 0.524
Highest respiratory rate 22.6 (0.86) 21.0 (0.72) 0.282
Time in recovery (mins) 18.8 (1.73) 17.3 (2.50) 0.644Respiratory Research 2005, 6:53 http://respiratory-research.com/content/6/1/53
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0.12, N = 58, Figure 5B). This was sufficient RNA to use
both for microarray analysis (1 µg) and real-time PCR
analysis (0.5 µg).
Preliminary data from the microarrays showed that gene
expression in epithelial cells from asthmatic subjects was
significantly different to that in healthy subjects (Figure
6). Expression of genes in the asthmatic cohort ranged
from 6-fold up-regulated to 5-fold down-regulated com-
pared to expression in the healthy controls.
Discussion
We have demonstrated that non-bronchoscopic brushing
is safe and well tolerated in children. The main symptom
reported following brushing was cough, which was
reported more frequently by parents than the nursing
staff. The procedure was acceptable to participants, as
none of the patients experienced symptoms that would
cause the parents not to recommend the study to a friend.
Respiratory variables and symptoms in children undergo-
ing brushing were no different in asthmatics compared to
non-asthmatics (table 2). The level of cough reported by
parents was increased in asthmatic children, however this
difference was not significant. The difference was most
likely due to increased observation of their child's symp-
toms, as there was no difference in the level of cough
reported by nursing staff in asthmatic and non-asthmatic
children.
The non-bronchoscopic brushing technique was able to
harvest useful quantities of epithelial cells, with a mean
viability of 17.3%. Studies in adult asthmatics, harvesting
cells under direct vision, report average viability ranging
from 25–30%, with a significantly lower viability in the
asthmatic epithelial cells [1,7,8]. In this study, the viabil-
ity of the epithelial cells was not significantly different in
the asthmatics. This may reflect the mild nature of asthma
experienced by these children, as previous studies have
reported the level of viability is correlated with the severity
of the disease [8].
This report outlines a broad range of techniques that can
be used to study a single sample of airway epithelium,
thus maximising the information obtained from one
brushing of the airway. Previous studies conducted in
children have detailed only limited use of the sample [2].
We report that it is possible to obtain cells of sufficient
quality and quantity to allow investigation using cell cul-
ture, immunohistochemistry, western blotting, real-time
PCR, and microarray. We have used immunocytochemi-
cal staining to examine expression of protein, and suffi-
cient protein can be extracted to perform Western blot
analysis. We have cultured the epithelial cells, and can
maintain and propagate the cultures successfully over
seven passages. Whilst non-bronchoscopic brushings of
the paediatric airway are easily and safely obtained, it is
important to maximise the amount of information
A: Histogram of number of cells sampled in 151 non-bronchoscopic brushings of the paediatric airway Figure 1
A: Histogram of number of cells sampled in 151 non-bronchoscopic brushings of the paediatric airway. The number of cells 
retrieved ranged between 0.1 million and 11.8 million (mean 2.7 million). B: Histogram of the percentage of viable cells in 43 
non-bronchoscopic brushings of the airway. The mean viability was 17.3%.Respiratory Research 2005, 6:53 http://respiratory-research.com/content/6/1/53
Page 6 of 10
(page number not for citation purposes)
obtained from each brushing. To this end, we have out-
lined a program of non-bronchoscopic brushing that
utilises a wide range of techniques, allowing a broad
approach to the study of the airway epithelium in
children.
Conclusion
The purpose of this study was to demonstrate how a single
sample of airway epithelial cells obtained by non-bron-
choscopic brushing can be used to study gene and protein
expression and provides sufficiently viable cells to allow
cell cultures to be established for functional analysis. The
technique is particularly useful for studying the paediatric
airway because it is simple and minimally invasive, and
can be used to overcome a major obstacle to our under-
standing of paediatric respiratory disease namely a paucity
of target organ tissue. We have presented data that can be
used by other groups to establish similar programs,
bench-mark for quality assurance and respond to com-
mon questions by human research ethics committees.
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Appendix
Parent Information Sheet
Does raised exhaled nitric oxide reflect unrecognised airway 
inflammation in healthy children?
You are being invited to take part in a research study.
Before you decide, it is important for you to understand
why the research is being done and what it will involve.
Please take time to read the following information
carefully. Ask us if there is anything that is not clear or if
Immunocytochemical confirmation of epithelial cell phenotype Figure 2
Immunocytochemical confirmation of epithelial cell phenotype. A: Pan-cytokeratin, B: α -smooth muscle actin, C: Smooth mus-
cle myosin, D: Vimentin.Respiratory Research 2005, 6:53 http://respiratory-research.com/content/6/1/53
Page 7 of 10
(page number not for citation purposes)
you would like more information. Take time to decide
whether or not you wish to take part.
GENERAL INFORMATION:
Nitric oxide (NO) is a molecule that is involved in many
physiological processes in the body including inflamma-
tion. NO is detectable in exhaled breath (eNO) and is
raised in asthmatics. Many studies have demonstrated
that exhaled NO might be a useful marker of airway
inflammation in asthma thus aiding diagnosis and moni-
toring of disease activity. However, children who respond
to skin allergy tests (atopic) and who do not have any res-
piratory symptoms also have raised eNO. We do not know
why eNO is raised in healthy atopic children but it may
also be due to inflammation in the airways that is not
presently causing respiratory problems. If we can deter-
mine what causes raised eNO in healthy atopic children
we will better understand how this test will help us mon-
itor airway disease.
"What will happen if I agree for my child to take part?"
The present study will use standard diagnostic techniques
to investigate whether inflammation that might not
otherwise be recognised is the cause of raised NO levels in
the breath of children with atopy. In order to study this
issue we will recruit children, WITH and WITHOUT
ATOPY, who are at Princess Margaret Hospital for day
surgery.
We will use the following strategy:
• You will be asked to complete a questionnaire about
your child's symptoms of allergy and asthma and medica-
tions that may effect eNO levels.
Percentage of basal cells in brushings obtained non-bronchoscopically from the paediatric airway Figure 3
Percentage of basal cells in brushings obtained non-bronchoscopically from the paediatric airway. A: Histogram of the percent-
age of basal cells in each brushing. On average, 10.04% of cells were basal cells. B: Percentage of basal cells retrieved in brush-
ings from each phenotype. The percentage of basal cells retrieved was not different depending on phenotype.
Phase-contrast micrograph of cultured epithelial cells Figure 4
Phase-contrast micrograph of cultured epithelial cellsRespiratory Research 2005, 6:53 http://respiratory-research.com/content/6/1/53
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• If your child is old enough they will be asked to blow
into a machine to determine their eNO levels. This may
occur either before the operation or at the time of their
next appointment.
• During surgery we will obtain a brushing of the surface
of the windpipe.
• A blood sample will be taken for allergy testing to com-
mon allergens. It will also be used for gene testing for NO
genes and asthma genes.
Measurements we will make:
1. Prior to surgery
Exhaled nitric oxide – To measure eNO we will ask your
child to take a deep breath in and blow into a machine
while trying to maintain a constant expiratory flow.
2. During surgery
Brushings – To collect cells from the wall of the airways
we will pass a fine brush through the larynx (voice box)
into the windpipe and rub along the wall of the windpipe
a few centimetres below the vocal cords. If you wish, we
will demonstrate the techniques and equipment used
before you decide to go ahead.
Blood sample – Blood will be collected once your child is
asleep.
Risks:
The brushing is a simple test and takes less than 5 minutes
to complete. In adults it is performed without an anaes-
thetic. The test will not be carried out if your child's anaes-
thetist or surgeon believes the test will interfere with your
child's treatment. We have routinely performed hundreds
of these tests without incident. A dry cough is the only
adverse symptom reported, it seems to occur in approxi-
mately half of the children involved in our study.
Benefits:
We will be able to provide you with information regarding
the allergic status of your child.
All information that is collected about your child during
the course of the research will be kept strictly confidential.
Any information about your child that leaves the hospital
will have your/his/her name and address removed so that
you/he/she cannot be recognised from it.
It is up to you to decide whether or not to take part. If you
decide to take part you will be given this information
sheet to keep and be asked to sign a consent form. If you
decide to take part you are still free to withdraw at any
Quantity and quality of RNA extracted from brushings obtained non-bronchoscopically from the paediatric airway Figure 5
Quantity and quality of RNA extracted from brushings obtained non-bronchoscopically from the paediatric airway. A: Histo-
gram of the amount of RNA extracted. On average, 2.9 µg of RNA was extracted from 2 ml of cell suspension. B: Histogram of 
the quality of RNA. The ribosomal RNA ratio was used as a measure of RNA quality; on average the RNA quality was 1.52.Respiratory Research 2005, 6:53 http://respiratory-research.com/content/6/1/53
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time and without giving a reason. This will not affect the
standard of care your child receives.
If you have any complaints about any aspect of the study
you can contact the Executive Director Medical Services of
PMH (Dr Geoff Masters) on 9340 1550
Thank you for reading this information sheet.
If you have any further questions with regard to this
study they can be discussed with
Dr Stephen Stick (Telephone 9340 8830)
Dr Scott Burgess (Hospital switch board – Telephone
9340 8222 page 2025 at any time)
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